Polaris Partners — 2017 Investments
5 investments dated 2017 · listed companies and verified rows first · show all
Cardlytics operates a commerce media platform that uses card-linked purchase data to deliver targeted offers and closed-loop measurement for marketers and advertisers, and personalized rewards programs for banks and publishers.
AdTechFintechMarketing TechAtlanta, US
Scott Grimes(Executive Officer, Director)inLynne Laube(Executive Officer, Director)Kirk Somers(Executive Officer)David Evans(Executive Officer)
BoardJohn Klinck(Director)inMark Johnson(Director)in
Board seatBryce Youngren· per SEC Form D · $11.9M raise · filed Jun 2017
Co-investorsBaroda VenturesCanaan PartnersKinetic Ventures, L.L.C.Next Coast VenturesSavano Capital PartnersHyperplane Venture Capital+1 more
Clinical-stage biopharmaceutical company focused on discovery and development of innovative medicines for serious diseases by targeting the Transforming Growth Factor Beta pathway.
BiotechCambridge, US
Nagesh Mahanthappa(Executive Officer, Director)Timothy Springer(Director)Yung H. Chyung(Executive Officer)Elan Z. Ezickson(Executive Officer)Alan Buckler(Executive Officer)
Board seatAmir Nashat· per SEC Form D · $47M raise · filed Jan 2018
Co-investorsSamsara BioCapitalARCH Venture Partners
BiotechBoston, US
Omid Farokhzad(Director)Philip Ma(Executive Officer)Shadi Aryanpour(Executive Officer)David Singer(Director)
BoardRobert Langer(Director)
Board seatTerrance McGuire· per SEC Form D · $6M raise · filed Jan 2018
Vaccinex is a clinical-stage biotechnology company developing pepinemab (VX15/2503), a humanized monoclonal antibody that blocks SEMA4D signaling, in trials for neurological disorders such as Huntington's and Alzheimer's disease and for solid tumors including breast cancer, melanoma, non-small cell lung cancer and head and neck cancer.
BiotechHealthtechMedical DevicesRochester, US
Maurice Zauderer, Ph.D.(Director, Executive Officer)Maurice Zauderer(Executive Officer, Director)Elizabeth Evans(Executive Officer)Ernest S. Smith Ph.D.(Executive Officer)Jill Sanchez(Executive Officer)Ernest S. Smith(Executive Officer)
Board seatAlan Crane· per SEC Form D · $18.2M raise · filed Jul 2017
New York, US
Mark Alexander(Executive Officer, Director)Anthony Sciortino(Executive Officer)John Heath(Executive Officer)Brant Wutzl(Executive Officer)Gregg Rubin(Executive Officer, Director)
BoardHallbjorn Karlsson(Director)
Board seatTerrance McGuire· per SEC Form D · $9.1M raise · filed Jan 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.